Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy
- 2 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Endocrinological Investigation
- Vol. 44 (10), 2227-2234
- https://doi.org/10.1007/s40618-021-01528-1
Abstract
Pretreatment staging is the milestone for planning either surgical or endoscopic treatment in duodenal neuroendocrine neoplasms (dNENs). Herein, a series of surgically treated dNEN patients was evaluated to assess the concordance between the pre- and postsurgical staging.Keywords
This publication has 42 references indexed in Scilit:
- Treatment of ampullary neuroendocrine tumor by endoscopic snare papillectomyThe American Journal of Case Reports, 2013
- Endoscopic resection of duodenal bulb neuroendocrine tumor larger than 10 mm in diameterBMC Gastroenterology, 2011
- Periampullary carcinoid tumorEndoscopy, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)Neuroendocrinology, 2006
- Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatmentBest Practice & Research Clinical Gastroenterology, 2005
- Early‐stage carcinoids of the gastrointestinal tractCancer, 2005
- Local Endoscopic Removal of Duodenal Carcinoid TumorsEndoscopy, 2004
- Endoscopic Mucosal Resection in the Management of Gastric Carcinoid TumorsEndoscopy, 2003
- Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.Gut, 1996